Anti inflammatory Flashcards
H1 activation leads to
- Increase capillary dilation via NO leading to Decrease BP
- Increase capillary permeability leading to edema
- Increased bronchiolar smooth muscle contraction
- Increas activation of peripheral nociceptive receptors increase pain and pruritis
- Decrease AV nodal conduction
H2 activation leads to
- Increas gastic acid secretion leading to ulcers
- Increase SA nodal rate
Diphenhydramine M block, Sedaiton, Antimotion
H1 Antagonist
- M Block: +++
- Sedation: +++
- Antimotion: +++
Promethazine M block, Sedaiton, Antimotion
H1 Blocker
- M Block: +++
- Sedation: +++
- Antimotion: +++
- Some alpha block and local anesthetic action
Chlorpheniramine M block, Sedaiton, Antimotion
H1 Blocker
- M Block: ++
- Sedation: ++
- Antimotion: ++
Meclizine M block, Sedaiton, Antimotion
H1 Block
- M Block: ++
- Sedation: ++
- Antimotion: +++
- Highly effective for motion sickness
Cetirizine M block, Sedaiton, Antimotion
H1 Blocker
- M Block: +/-
- Sedation: +
- Antimotion: 0
- Only sedation
Loratadine M block, Sedaiton, Antimotion
H1 Blocker
- M Block: +/-
- Sedation : 0
- Antimotion: 0
- No CNS entry
Fexofenadine M block, Sedaiton, Antimotion
H1 Blocker
- M Block: +/-
- Sedation: 0
- Antimotion: 0
- No CNS entry
H2 antagonist drugs
- Cimetidine
- Ranitidine
- Famotidine
- -TIDINE
H2 antagonist used for
Peptic Ulcer Disease, GERD, and Zolwinger by suppressing secretory response to food stimulation
Cimetidine adverse affects
- Major P450 inhibitor
- Decrease androgens leading to gynecomastia and decrease libido
Omeprazole (-Prazole) mechanism of action
- Irreversible proton pump in gastric parietal cells
- K/H antiport inhibitor
Misoprostol mechanism of action
PGE1 analog that is cytoprotective by increasing mucus and bicarbonate secretion and decrease HCL secretion
Sucralfate mechanism of action
- Polymerizes on GI luminal surface to form a protective gel-like coating of ulcer bed
- Requires acid pH to activated
Ondansteron (-steron) mechanism of action and use
5HT3 antagonist that prevents Nausea and vomiting in Cancer Pts.
DA antagonists
- Prochlorperazine
- Meoclopramide
DA antagonists used for
Prevent Nausea and vomiting in Cancer Pt.
Aprepitant mechanism of action
NK1 receptor antagonist
(receptor for substance P)
Buspirone mechanism of action
5HT1a partial agonist used for GAD
-TRIPTANS mechanism of action
Agonist at 5HT1d receptors in cerebral vessels leading to decrease migraine pain
-Triptan adverse affects
- Asthenia
- Chest or throat pressure or pain
5HT1(a-h) found in
- CNS (inhibitory)
- Smooth muscle (excitatory or inhibitory)
5HT2(a-c) found in
CNS (excitatory)
Cyproheptadine mechanism of action
5HT2 antagonised used in carcinoid, GI tumors, and Anorexia nervosa
5HT3 found in
- Area prostrema
- Peripheral sensory
- Enteric nerves
Ergotamine mechanism of action
- Partial agonist at both alpha and 5HT2 receptors in the vasculature and possibly in the CNS
- Vasoconstrictive action to decrease pulsation in cerebral vessels may prevent acute action of Ergotamine during migration
Ergotamine used for
Accute attacks of migraine headache